For individuals grappling with obesity or overweight-related health issues such as type 2 diabetes, high blood pressure, or high cholesterol, Semaglutide GLP-1 could offer a viable solution
Nausea management GLP-1 nausea typically peaks during the first few weeks at each new dose level
Carrying too much fat around the middle can make it harder for your body to manage blood sugar, leading to insulin resistance, and raise levels of harmful cholesterol, all of which can affect long-term health
For a 220-pound person, thats 33 pounds with semaglutide versus 53 pounds with retatrutide
Possible gastrointestinal side effects, including nausea, bloating, or constipation, as the body adapts to the medication